Nuwellis, Inc. (NUWE) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
NUWE Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Nuwellis, Inc. (NUWE) trades at a price-to-earnings ratio of -0.0x, with a stock price of $1.10 and trailing twelve-month earnings per share of $-10.85.
The current P/E is 104% below its 5-year average of 1.0x. Over the past five years, NUWE's P/E has ranged from a low of 0.7x to a high of 1.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, NUWE trades at a 100% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, NUWE trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NUWE DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NUWE P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 25.2 | 0.69 | -65% | |
| $4B | 29.3 | - | +5% | |
| $56B | 26.3 | 1.59 | -1% | |
| $84B | 29.2 | - | +55% | |
| $100B | 21.6 | - | +31% | |
| $48B | 45.2 | 6.39 | -74% | |
| $151B | 11.4Lowest | 0.38Best | +134%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
NUWE Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $9.26 | $10.96 | 0.8x | -16% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $39.48 | $53.09 | 0.7x | -26% |
| FY2024 Q4 | $46.62 | $32.68 | 1.4x | +42% |
Average P/E for displayed period: 1.0x
See NUWE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NUWE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NUWE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNUWE — Frequently Asked Questions
Quick answers to the most common questions about buying NUWE stock.
Is NUWE stock overvalued or undervalued?
NUWE current P/E: -0.0x. 5-year average P/E: 1.0x. Percentile: N/A.
How does NUWE's valuation compare to peers?
Nuwellis, Inc. P/E of -0.0x compares to sector median of 22.3x. Sector comparison provides relative valuation context.
What is NUWE's PEG ratio?
NUWE PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.